Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease

Terapevticheskii Arkhiv

Volumn 76, Issue 8, 2004, Pages 61-68

  Vasilyev, V I ^a   Probatova, N A ^a   Varlamova, Ye Yu ^a   Tupitsyn, N N ^a   Simonova, M V ^a   Safonova, T N ^a   Bozhieva, L A ^a   Shornikova, N S ^a   Logvinenko, O A ^a   Belinin, G Yu ^a   Gorodetsky, V R ^a   Radenska Lopovok, S G ^a  

^a NONE

Author keywords

Monoclonal cryoglobulinemia; Prognostic value; Sjogren 's disease

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; PARAPROTEIN; PROTEIN DERIVATIVE; RHEUMATOID FACTOR; CRYOGLOBULIN; MONOCLONAL ANTIBODY; TUMOR MARKER;

AGAR GEL ELECTROPHORESIS; ARTICLE; B LYMPHOCYTE; BIOLISTIC TRANSFORMATION; BONE MARROW BIOPSY; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOGLOBULINEMIA; CYTOTOXICITY; DISEASE MARKER; HISTOCHEMISTRY; HUMAN; IMMUNE DEFICIENCY; IMMUNOASSAY; IMMUNOPHENOTYPING; LOWER LIP; LYMPH NODE BIOPSY; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MICROMORPHOLOGY; MIXED MONOCLONAL CRYOGLOBULINEMIA; MONOCYTOSIS; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SALIVARY GLAND; STATISTICAL SIGNIFICANCE; VASCULITIS; ADOLESCENT; ADULT; AGED; BLOOD; FEMALE; IMMUNOLOGY; LUNG; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SJOEGREN SYNDROME; SKIN;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HUMANS; LUNG; LYMPHOMA; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RHEUMATOID FACTOR; SALIVARY GLANDS; SJOGREN'S SYNDROME; SKIN; TUMOR MARKERS, BIOLOGICAL;

EID: 4644297337     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lerner A. B., Watson C. J. Studies of cryoglobulins. Am. J. Med. Sci. 1947; 214: 410-416.
2. Ferri C., Zignego A. L., Pileri S. A. Cryoglobulins. J. Clin. Pathol. 2002; 55: 4-13.
3. Brouet J. C., Clauve J. P., Danon F. et al. Biological and clinical significance of cryoglobulins. Am. J. Med. 1974; 57: 775-788.
4. Anfimova M. L., Lebedeva T. V., Vassiliev V. I. et al. Fibronectin, cryoglobulinemia and immune complexes of patients with Sjogren's syndrome. Rus. J. Immunol. 1996; 1: 30-34.
5. Leva Y. Cryoproteins, cryoimmunoglobulinemia and cryofibrinogenemia. Advanc. Microcirc. 1982; 10: 73-94.
6. Tep. apx. 1990; 5: 66-70.
7. Tziofas A. G., Moutsopoulos H. M., Costello R. et al. Cryoglobulinemia in autoimmune rheumatic diseases: evidence of circulating monoclonal cryoglobulins in primary Sjogren's syndrome. Arthr. and Rheum. 1986; 29: 1098-1104.
8. Moutsopoulos H., Steinberg A., Fanci A. et al. High incidence of free monoclonal λ light chains in the sera of patients with Sjogren's syndrome. J. Immunol. 1983; 130: 2663-2665.
9. Moutsopoulos H., Costello R., Drosses A. A. et al. Demonstration and identification of monoclonal proteins in the urine of patients with Sjogren's syndrome. Ann. Rheum. Dis. 1985; 44: 109-112.
10. Tep. apx. 1987; 11: 54-59.
11. Alexander E. L. Inflammatory vascular disease in Sjogren's syndrome. In: Talal N., Moutsopoulos H. M., Kassan S. S., eds. Sjogren's syndrome. Berlin; 1987. 102-125.
12. Tziofas A. G., Moutsopoulos H. M., Talal N. Lymphoid malignancy and monoclonal proteins. In: Talal N., Moutsopoulos H. M., Rassan S. S., eds. Berlin; 1987. 129-136.
13. Tep. apx. 1978; 9: 108-114.
14. Anderson L. G., Talal N. The spectrum of benign to malignant lymphoproliferation in Sjogren's syndrome. Clin. Exp. Immunol. 1971; 9: 199-221.
15. Sugai S., Saito I., Masari Y. Expression and rearrangement of rheumatoid factor-related germline gene Vg in lymphoproliferative disorders in patient with Sjogren's syndrome. In: Homma M., Sugai S., Tojo T., eds. Sjogren's syndrome. Amsterdam; New York; 1994. 213-218.
16. Voulgarelis M., Dafni V. A., Isenberg D. A. et al. Malignant lymphoma in primary Sjogren's syndrome. Arthr. and Rheum. 1999; 42: 1765-1772.
17. Kassan S. S., Thomas T. L., Moutsopoulos H. M. et al. Increased risk of lymphoma in Sicca syndrome. Ann. Intern. Med. 1978; 89: 888-892.
18. Cavalli F., Isaacson P. G., Gascoyne R. D. et al. MALT-lymphomas. Hematology 2001; 4: 241-258.
19. Voulgarelis M. Autoimmunity and lymphoma. Haema 2002; 5: 93-99.
20. Tziofas A. G., Boumba D. S., Skopouli F. N., Moutsopoulos H. M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predective factors the development of lymphoma in primary Sjogren's syndrome. Arthr. and Rheum. 1996; 39: 767-772.
21. Jonsson R., Gordon T. P., Kouttinen Y. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profill of Sjogren's syndrome. Curr. Rheumatol. Rep. 2003; 5: 311-316.
22. Manuilova L. S., Vasilyev V. I., Simonova M. V. Clinico-immunological aspects of vasculitis in Sjogren's disease. Clin. Exp. Rheumatol. 1991; 9 (3): 328.
23. Tapinos N. I., Polihronis M., Tzioufas A. G. Immunopathology of Sjogren's syndrome. Ann. Med. Intern. 1998; 149: 17-24.
24. Gorodetskiy V. R., Vasilyev V. I., Probatova N. A. et al. Lymphomas in patients with Sjogren's syndrome. J. Cancer 2002; 13: 401.
25. Voulgarelis M., Moutsopoulos H. Malignant lymphoma in primary Sjogren's syndrome. IMAJ 2001; 3: 761-766.
26. Harris N. L. Lymphoid proliferations of the salivary glands. Am. J. Clin. Pathol. 1999; 111 (suppl. 1): 94-102.
27. Fox R. J., Stern M. Sjogren's syndrome: mechanisms of pathogenesis in volve intraction of immune and neurosecretory systems. Scand. J. Rheumatol. 2002; 31 (suppl. 116): 3-13.